Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia
暂无分享,去创建一个
S. Shurtleff | S. Raimondi | Cheng Cheng | D. Campana | C. Pui | R. Ribeiro | E. Coustan-Smith | D. Pei | J. Choi | J. Rubnitz | S. Jeha | D. Bhojwani | S. Howard | M. Metzger | J. Sandlund | H. Inaba | J. Jacobsen | Deqing Pei